Natco Pharma Invests $14 Million in eGenesis
MM Desk
29 August, 2026
Natco Pharma Limited has invested US$14 million in eGenesis, Inc, a biotechnology company developing genetically
Natco Pharma Limited has invested US$14 million in eGenesis, Inc, a biotechnology company developing genetically
Coperion has introduced the AutoAccess automated rotary valve extraction system and WFV diverter valve to
Honeywell Technologies has announced leadership changes across its Process Technology and Building Automation businesses, with
Hertha Metals has achieved 99.95% (3N5) iron purity using fully domestic inputs, marking a major
Interroll Holding AG has acquired Interroll AS, its long-standing distributor in Norway, strengthening the company’s
The HAIMER Group will complete its generational ownership transition on August 1, 2026, with company
Rolls-Royce has completed a $1 billion, decade-long investment in its manufacturing, assembly and testing facilities
Tata Motors Passenger Vehicles Ltd (TMPV) has unveiled TATA.CARS, its new consumer-facing global brand identity,
Telawne Power Equipments brought together more than 60 energy consultants and power sector professionals at
Tigo Energy, Inc (NASDAQ: TYGO) and Ingeteam SA have completed compatibility testing for selected Ingeteam